跳至主要内容
临床试验/NCT02930525
NCT02930525已完成不适用

Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation: A Randomized Controlled Pilot Trial

University of Freiburg2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Respiratory instability

研究概览

简要总结

Procedural sedation is an established and safe intervention and is widely used in diagnostic and therapeutic procedures for pediatric patients. Nonetheless, problems of the respiratory system such as upper airway obstruction, hypoventilation and apnea are frequent adverse events. We postulate that respiratory instability is less frequent in patients high flow nasal cannula vs. standard care on respiratory stability, i.e. low flow nasal cannula, in pediatric procedural sedation. The purpose of this pilot study is to estimate the effect of HFNC (high flow nasal cannula) on the respiratory instability in children undergoing upper gastrointestinal endoscopy under pediatric procedural sedation (PPS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 6 years - 18 years
  • Undergoing pediatric non-emergency upper gastrointestinal endoscopy under sedation
  • Informed consent/assent for enrollment by parents/legal guardians/patient

排除标准

  • Congenital or acquired malformations involving the airways
  • Patients with the history of spontaneous pneumothorax or connectives tissue diseases (Marfan syndrome, Ehlers-Danlos-Syndrome)
  • Patients with a history of traumatic/iatrogenic air leak within the last 3 months before enrollment

结局指标

主要结局

Respiratory instability

时间窗: Time frame from first applications of intravenous sedatives until finishing the intended procedure

Number of episodes longer than 15 seconds with SpO2 \< 93% and/ or pCO2 \> 45 mmHg and/ or apnea (defined as cessation of airflow for \> 15 seconds)

次要结局

  • Number of interventions to regain respiratory stability(Time frame from first applications of intravenous sedatives until finishing the intended procedure)
  • Duration of respiratory instability(Time frame from first applications of intravenous sedatives until finishing the intended procedure)
  • Need for noninvasive ventilation(Time frame from first applications of intravenous sedatives until finishing the intended procedure)
  • Use of sedatives(Time frame from first applications of intravenous sedatives until finishing the intended procedure)
  • Use of analgesics(Time frame from first applications of intravenous sedatives until finishing the intended procedure)
  • Time of procedure in minutes(Duration of the procedure for which sedation is determined. It covers the time period from first positioning of the patient to repositioning of the patient or patients extremities after completion of the procedure)
  • Time of sedation in minutes(Time frame from first applications of intravenous sedatives until finishing the intended procedure)
  • Nausea and vomiting(24 hours after procedural sedation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Klotz

M.D.

University of Freiburg

研究点 (2)

Loading locations...

相似试验